In IBD, both innate and adaptive immune responses are abnormally activated in the intestinal mucosa, leading to the release of a similar set of cytokines, including TNF-α, IL-6, IL-12/23, and interferon-γ, which drive tissue injury [39]. Here, TNF is linked to inflammatory bowel disease.